Ethical controls of drug trials
Osswald, W.
Revista Portuguesa de Cardiologia Orgao Oficial da Sociedade Portuguesa de Cardiologia 18(9): 833-837
1999
ISSN/ISBN: 0870-2551 PMID: 10536474 Document Number: 510466
Document emailed within 1 workday
Related Documents
Sedivý, J.; Setka, J.; Rusek, J. 1992: The role of ethics committees in evaluating the ethical aspects of clinical drug trials Casopis Lekaru Ceskych 131(17): 539-540Bergmann, J.F.; Lagier, G.; Calvo, F.; Chazelle, F.; Caulin, C. 1988: Independent controls of quality in therapeutic trials. Apropos of an experience of 11 external audits of clinical investigators performed in 2 European multicenter trials Therapie 43(5): 379-384
Wilde, H.; Phaosavasdi, S.; Pruksapong, C.; Tannirandorn, Y.; Taneepanichskul, S. 1999: Ethics of using controls and placebo in clinical trials Journal of the Medical Association of Thailand 82(6): 632-635
Gehan, E.A. 1982: Design of controlled clinical trials: use of historical controls Cancer Treatment Reports 66(5): 1089-1093
Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
Uberla, K.K. 1981: Ethical questions in trials in humans as seen by the biometrician Münchener Medizinische Wochenschrift 123(17): 701-705
Kardinal, C.G. 1994: Ethical issues in cancer clinical trials Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 146(8): 359-361
Chadly, A. 2004: Ethical implications of clinical trials in Tunisia La Tunisie Medicale 82(11): 985-989
Lindegger, G.; Slack, C.; Vardas, E. 2000: HIV vaccine trials in South Africa--some ethical considerations South African Medical Journal 90(8): 769-772
Arpaillange, P.; Dion, S.; Mathé, G. 1986: Proposals for ethical standards in therapeutic trials with humans Drugs under Experimental and Clinical Research 12(1-3): 11-19
Junkes, V. 2005: Quicker ethical trials with correctly filled in forms Lakartidningen 102(35): 2428; Author Reply 2428
Durry, G.; Dion, S. 1986: The ethical approach to phase I clinical trials in oncology Drugs under Experimental and Clinical Research 12(1-2): 21-22
Tharyan, P.; Ghersi, D. 2008: Registering clinical trials in India: a scientific and ethical imperative National Medical Journal of India 21(1): 31-34
de Zoysa, I.; Elias, C.J.; Bentley, M.E. 1998: Ethical challenges in efficacy trials of vaginal microbicides for HIV prevention American Journal of Public Health 88(4): 571-575
Brierley, J.; Larcher, V. 2014: Clinical trials of contraceptive agents in those under 16 years of age: are they necessary, ethical or legal? Archives of disease in childhood 99(12): 1070-1073
Astrup, K.G.; Riis, P. 1995: Drug approval. Orientation from the drug department of the National Board of Health and Welfare and the scientific-ethical committee system Ugeskrift for Laeger 157(46): 6442-6443
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907
Jesani, A.; Coutinho, L. 2007: AIDS vaccine trials in India: ethical benchmarks and unanswered questions Indian Journal of Medical Ethics 4(1): 2-3
Essack, Z.; Koen, J.; Barsdorf, N.; Slack, C.; Quayle, M.; Milford, C.; Lindegger, G.; Ranchod, C.; Mukuka, R. 2010: Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa Developing World Bioethics 10(1): 11-21
Müller-Oerlinghausen, B. 1983: The placebo problem. Individual and socio-ethical considerations on controlled therapeutic trials Münchener Medizinische Wochenschrift 125(5): 80-84